Nitrous oxide and Xenon

Nitrous oxide: role in anesthesiology and pharmacokinetics

This drug has relatively weak narcotic potency. For this reason, in modern clinical practice, it is almost never used as monotherapy. Most often, it is included in combined anesthesia regimens, combined with more potent anesthetic agents to ensure an adequate depth of drug-induced sleep.

As for pharmacokinetics, the drug behaves extremely simply in the body:

• It does not undergo metabolic transformations (biotransformation in the liver or other organs) at all.
• The elimination process is carried out almost entirely through the respiratory system. The gas leaves the body through the lungs in its original, unchanged form.

Safety profile and adverse effects of nitrous oxide

The safety of use largely depends on the duration of inhalation. With short-term use, the drug demonstrates an excellent safety profile—adverse reactions in such situations are virtually absent.

However, prolonged inhalations pose a serious threat to the patient's health. There is a high risk of developing severe complications from the hematopoietic and nervous systems:

1. Leukopenia (decreased leukocyte count).
2. Megaloblastic anemia.
3. Neuropathy.

The mechanism of toxicity consists of a direct chemical effect on vitamin B12. The drug causes oxidation of the cobalt atom, which is the central element in the structure of the cyanocobalamin molecule. As a result, marked functional vitamin B12 deficiency develops.

In addition, drug interactions should be taken into account. When co-administered with anesthetic support agents such as narcotic analgesics or neuroleptics, hemodynamic depression may develop. Clinically, this manifests as a marked decrease in blood pressure (BP) and a drop in cardiac output.

Xenon: properties of an inert gas

Unlike nitrous oxide, xenon is a noble (inert) gas. One of its key physicochemical characteristics is an extremely low blood/gas partition coefficient. In practice, this means that the drug saturates blood and tissues very quickly, ensuring rapid induction of the patient into anesthesia.

From a pharmacodynamic standpoint, this gas has a number of unique advantages:

• Powerful analgesia: the drug provides a high degree of pain relief.
• Lack of toxicity: does not damage cellular structures and enzyme systems.
• Cardiostability: the gas has absolutely no effect on myocardial contractility, maintaining stable cardiac function.
• Neuroprotective effect: protects neurons from damaging factors during surgery.

Mechanisms of action and disadvantages of xenon

The drug's effects are mediated through complex interactions with the receptor apparatus of the central nervous system. The main mechanism consists of the non-competitive blockade of NMDA receptors. Additionally, the gas exerts a modulating effect on GABA-A receptors and affects a number of other glutamate receptors (besides NMDA), which together ensure the rapid onset of the surgical stage of anesthesia and powerful analgesia.

Despite a profile close to an ideal anesthetic, widespread use is limited by two significant disadvantages:

• Extremely high cost of the drug itself.
• The need to equip operating rooms with specialized and expensive anesthesia equipment capable of operating with this gas in a closed circuit.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• Principles of combined anesthesia: which drugs are combined with nitrous oxide.
• Biochemical basis of functional vitamin B12 deficiency during nitrous oxide inhalation.
• Mechanisms of hemodynamic depression when combining inhalational anesthetics with neuroleptics.
• Technical features of anesthesia equipment required for xenon anesthesia.
• The role of GABA-A and NMDA receptors in the formation of the analgesic and neuroprotective effects of xenon.

Other topics in the "Special Pharmacology" section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.